Azilsartan prevents muscle loss and fast- to slow-twitch muscle fiber shift in natural ageing sarcopenic rats
Canadian Journal of Physiology and Pharmacology · 2024
DOI: 10.1139/cjpp-2023-0265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2024. Verfasst von Priyanka Prajapati und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow…. Hauptthemen laut MEDLINE: Sarcopenia, Oxadiazoles, Aging, Rats, Sprague-Dawley. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research, Science and Engineering Research Board.
Abstract (Originalsprache)
Sarcopenia is a musculoskeletal disease that reduces muscle mass and strength in older individuals. The study investigates the effects of azilsartan (AZL) on skeletal muscle loss in natural sarcopenic rats. Male Sprague-Dawley rats aged 4–6 months and 18–21 months were selected as young-matched control and natural-aged (sarcopenic) rats, respectively. Rats were allocated into young and old control (YC and OC) and young and old AZL treatment (YT and OT) groups, which received vehicles and AZL (8 mg/kg, orally) for 6 weeks. Rats were then sacrificed after muscle function analysis. Serum and gastrocnemius (GN) muscles were isolated for further endpoints. AZL significantly improved muscle grip strength and antioxidant levels in sarcopenic rats. AZL also restored the levels of insulin, testosterone, and muscle biomarkers such as myostatin and creatinine kinase in sarcopenic rats. Furthermore, AZL treatment improved the cellular and ultrastructure of GN muscle and prevented the shift of type II (glycolytic) myofibers to type I (oxidative) myofibers. The results showed that AZL intervention restored protein synthesis in natural sarcopenic rats by increasing p-Akt-1 and decreasing muscle RING-finger protein-1 and tumor necrosis factor alpha immunoexpressions. In conclusion, the present findings showed that AZL could be an effective intervention in treating age-related muscle impairments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow 226025, India.
- Department of Pharmacology, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur 441002, India.
- Priyadarshini J.L. College of Pharmacy, Electronic Zone Building, MIDC Hingna Road, Nagpur 440016, India.
- National Institute of Pharmaceutical Education & Research, Raebareli (NIPER-R), Near CRPF Base Camp, Sarojini Nagar, Lucknow 226002, India.
ORCID-Profile: Sapana Kushwaha
Förderung
- Indian Council of Medical Research
- Science and Engineering Research Board
Zitieren
APA
Prajapati, P., Kumar, A., Mangrulkar, S., Chaple, D. R., Saraf, S. A., & Kushwaha, S. (2024). Azilsartan prevents muscle loss and fast- to slow-twitch muscle fiber shift in natural ageing sarcopenic rats. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2023-0265
Vancouver
Prajapati P, Kumar A, Mangrulkar S, Chaple DR, Saraf SA, Kushwaha S. Azilsartan prevents muscle loss and fast- to slow-twitch muscle fiber shift in natural ageing sarcopenic rats. Canadian Journal of Physiology and Pharmacology. 2024. doi:10.1139/cjpp-2023-0265
BibTeX
@article{Prajapati2024,
author = {Prajapati, Priyanka and Kumar, Anand and Mangrulkar, Shubhada and Chaple, D R and Saraf, Shubhini A and Kushwaha, Sapana},
title = {Azilsartan prevents muscle loss and fast- to slow-twitch muscle fiber shift in natural ageing sarcopenic rats},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2024},
doi = {10.1139/cjpp-2023-0265}
}
EUVIMED